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Autism spectrum disorders such as Rett syndrome
(RTT) have been hypothesized to arise from defects
in experience-dependent synapse maturation. RTT
is caused by mutations in MECP2, a nuclear protein
that becomes phosphorylated at S421 in response
to neuronal activation. We show here that disruption
of MeCP2 S421 phosphorylation in vivo results in
defects in synapse development and behavior, impli-
cating activity-dependent regulation of MeCP2 in
brain development and RTT. We investigated the
mechanism by which S421 phosphorylation regu-
lates MeCP2 function and show by chromatin immu-
noprecipitation-sequencing that this modification
occurs on MeCP2 bound across the genome. The
phosphorylation of MeCP2 S421 appears not to
regulate the expression of specific genes; rather,
MeCP2 functions as a histone-like factor whose
phosphorylation may facilitate a genome-wide
response of chromatin to neuronal activity during
nervous system development. We propose that
RTT results in part from a loss of this experience-
dependent chromatin remodeling.
INTRODUCTION
Mutations inMECP2 cause Rett syndrome (RTT), a human neu-
rodevelopmental disorder that can lead to cognitive impairment,
autistic features, motor disabilities, seizures, and anxiety (Chah-
rour and Zoghbi, 2007). Experiments that disrupt MeCP2
expression in specific populations of cells in mice indicate that
dysfunction of neurons throughout the central nervous system
contributes to the symptoms associated with RTT (Guy et al.,
2010). However, the molecular mechanism by which disruptions
in MeCP2 function give rise to neuronal dysfunction remains
poorly understood.72 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.MeCP2was identified based on its affinity formethylated cyto-
sines within DNA (Lewis et al., 1992). Because DNA methylation
has been associated with transcriptional inhibition and because
MeCP2 contains a domain that can mediate transcriptional
repression in vitro (Nan et al., 1997), it was suggested that
MeCP2 functions as a repressor of gene expression. Disruption
of MECP2 in RTT was predicted to lead to the upregulation of
target genes, the identification of which might then be expected
to provide insight into the etiology of this disorder. Although both
genetic and molecular biological approaches have been used to
identify genes whose expression is regulated by MeCP2, the
changes in gene expression detected when MeCP2 function is
disrupted are small in magnitude, and are not entirely consistent
with the idea thatMeCP2 is a transcriptional repressor of specific
genes (Chahrour et al., 2008; Tudor et al., 2002; Yasui et al.,
2007). In conjunction with recent evidence that MeCP2 binds
broadly throughout the genome and affects nucleosome struc-
ture (Ghosh et al., 2010; Skene et al., 2010), these findings
suggest that, rather than acting as a sequence-specific tran-
scription factor, MeCP2 functions as a global regulator of chro-
matin structure. However, it remains to be determined how the
loss of MeCP2 function in the nucleus of neurons leads to a
disruption of chromatin architecture, and why this gives rise to
the defects associated with RTT.
The clinical course of RTT has provided clues as to the role of
MeCP2 in thematuration of the nervous system. RTT-associated
neuronal dysfunction first manifests itself in early postnatal life,
when sensory experience is required for the refinement of devel-
oping neuronal circuits. This observation suggests that MeCP2
might mediate some of the effects of experience on synapse
and neural circuit development, and that the absence of
activity-dependent regulation of MeCP2 in RTT contributes to
the etiology of this disorder.
In support of this idea, MeCP2 becomes newly phosphory-
lated at a specific amino acid residue, serine 421 in the brain in
response to sensory stimuli (S421 refers to mouse MeCP2 iso-
form 2 and corresponds to S438 in mouse MeCP2 isoform 1
and S423 in human MeCP2) (Deng et al., 2010; Murgatroyd
et al., 2009; Zhou et al., 2006). In cultured neurons, MeCP2
S421 phosphorylation is triggered by the release of glutamate
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regulate MeCP2 function as part of an adaptive response to
neuronal stimulation (Chen et al., 2003; Zhou et al., 2006). The
phosphorylation of MeCP2 at S421 has been suggested to
play a role in the neuronal activity-dependent induction of brain
derived neurotrophic factor (BDNF), a secreted protein that
promotes many aspects of experience-dependent synaptic
development. Consistent with this possibility, when MeCP2 is
overexpressed in neurons the phosphorylation of S421 affects
the development of neuronal dendrites and spines (Zhou et al.,
2006). The phosphorylation of S421 in response to neuronal
activity has also been suggested to reduce the binding of
MeCP2 to methylated DNA (Chen et al., 2003; Martinowich
et al., 2003), leading to the hypothesis that synaptic activity regu-
lates neuronal development by decreasing the affinity of MeCP2
for methylated cytosines within the regulatory regions of genes
such as Bdnf, resulting in a change in chromatin structure that
is required for gene activation.
The hypothesis that a disruption of activity-dependent gene
regulation gives rise to the synaptic defects associated with RTT
provides an attractive means to explain why identifying MeCP2
target genes under basal conditions has proven so challenging.
However, all of the data that implicate MeCP2 phosphorylation
in experience-dependent transcription and neuronal develop-
ment stem from experiments in which MeCP2 was studied
in vitro, using overexpression assays. It remains to be determined
whether activity-dependent regulation of MeCP2 is required for
brain development and if deficits in this process are sufficient
to explain the phenotypes observed in mouse models of RTT.
To investigate the importance of MeCP2 S421 phosphoryla-
tion for the development of the nervous system and the patho-
genesis of RTT, we generated a mouse in which MeCP2 S421
is converted to an alanine to prevent phosphorylation of this
residue.We find that loss ofMeCP2S421 phosphorylation in vivo
results in defects in dendritic and synaptic development and in
abnormal behavioral responses to novel experience, suggesting
that RTT is at least in part a disorder of experience-dependent
brain development. We investigated the mechanism by which
S421 phosphorylation regulates MeCP2 function and show by
chromatin immunoprecipitation followed by high-throughput
sequencing (ChIP-Seq) that this modification occurs on
MeCP2 bound across the genome. The phosphorylation of
MeCP2 S421 appears not to control the expression of specific
genes; rather, MeCP2 functions as a histone-like factor whose
phosphorylation regulates a genome-wide response of chro-
matin to neuronal activity during nervous system development.
These findings suggest that aspects of RTT result from a loss
of this experience-dependent chromatin remodeling.
RESULTS
Mutation of MeCP2 S421 Preserves Key Features
of MeCP2 Protein Function
To examine how neuronal activity-dependent MeCP2 phosphor-
ylation regulates brain development, we generated a knockin
mouse in which S421 of MeCP2 is mutated to an alanine
(S421A) (see Figure S1 available online). We reasoned that
disruption of MeCP2 S421 phosphorylation in vivo might provideinsight into how loss of activity-dependent MeCP2 regulation
contributes to RTT. Western blotting and immunohistochemistry
using an antibody that specifically recognizes MeCP2 when
phosphorylated at S421 confirmed that MeCP2 S421 phosphor-
ylation is eliminated in MeCP2 S421A mice (Figure 1A and Fig-
ure S1F). Membrane depolarization of cultured cortical neurons
by treatment with high extracellular potassium chloride (KCl) to
induce calcium influx into neurons induces a slowly-migrating
form of MeCP2 on an SDS-polyacrylamide gel that we have
previously shown is due to phosphorylation at S421 (Chen
et al., 2003; Zhou et al., 2006). This slowly-migrating form of
MeCP2 was not induced by membrane depolarization of cul-
tured neurons derived from the MeCP2 S421A knockin mice,
confirming that S421 has been converted to an amino acid that
cannot be phosphorylated (Figure 1B).
Precise regulation of MeCP2 protein levels is required for
proper nervous system function in humans and mice: both
MECP2 gene duplications in humans and two-fold overexpres-
sion of MeCP2 in mice result in a spectrum of symptoms that
overlap with those seen upon MeCP2 loss-of-function (Guy
et al., 2010). Thus our ability to draw conclusions as to the impor-
tance of MeCP2 S421 phosphorylation in vivo depends critically
on the maintenance of normal MeCP2 protein levels in MeCP2
S421A mice. Quantitative western blotting revealed that total
MeCP2 levels in the brains of MeCP2 S421A knockin mice and
their wild-type littermates are indistinguishable across a number
of developmental time points (Figure 1C and Figure S1G). Recent
evidence indicates that MeCP2 is expressed in both neuronal
and glial cells in the mouse brain (Ballas et al., 2009; Maezawa
et al., 2009). We used immunocytochemistry in cultured cortical
neurons to specifically determine if MeCP2 levels in neurons are
perturbed by the S421A mutation. The expression of MeCP2
protein, as indicated by the intensity of anti-MeCP2 immunore-
activity, is similar in wild-type and MeCP2 S421A cortical
neurons (Figure 1D). These findings indicate that the MeCP2
S421A mutation does not change the level of MeCP2 protein
expression in the brain.
MeCP2 associates predominantly with heterochromatic foci in
mouse cell nuclei in a DNA methylation-dependent manner, re-
sulting in a characteristic pattern of diffuse MeCP2 staining
throughout the nucleus, with prominent foci colocalizing with
pericentromeric heterochromatic regions (Nan et al., 1996). We
observed this pattern of staining with anti-MeCP2 antibodies in
neurons derived from both wild-type and MeCP2 S421A mice
(Figure 1D), indicating that mutation of MeCP2 S421 does not
disrupt the subnuclear distribution of MeCP2 in the nucleus
and suggesting that activity-dependent MeCP2 S421 phosphor-
ylation may not be required for targeting of MeCP2 to chromatin.
Although it remains possible that the conservative mutation of
S421 to alanine affects an undetected function of MeCP2 in
addition to eliminating activity-dependent phosphorylation of
this residue, we conclude that this mutation does not signifi-
cantly alter levels of MeCP2 expression or nuclear localization
of MeCP2. Given that the S421A mutation does not affect these
fundamental properties of the MeCP2 protein, we reasoned that
it should be possible to employ MeCP2 S421A knockin mice to
investigate the specific role of MeCP2 S421 phosphorylation
during brain development.Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 73
Figure 1. Selective Loss of the Activity-Dependent
Phosphorylation of MeCP2 S421 In Vivo Preserves
the Expression Level and Localization of MeCP2
(A)Western blot analysis of nuclear extracts prepared from
the forebrains of two 4-week-old male MeCP2 S421A
knockinmice (S421A KI) and their wild-type (WT) littermate
using antibodies specific to MeCP2 pS421, and total
MeCP2. Parallel blots for pS133 CREB and total CREB
show that there is no gross disruption of activity-depen-
dent signaling in the brain.
(B) Anti-total MeCP2 western blots of lysates from E16 + 5
DIV dissociated hippocampal neurons derived from
MeCP2 S421A knockin mice or wild-type littermates. (i)
Arrow indicates the S421 phosphorylation-dependent
slowly-migrating form ofMeCP2 induced by 60min 55mM
KCl stimulation in wild-type cells. (ii) Thirty minute pre-
treatment with okadaic acid (0.25 mM) to inhibit protein
phosphatase activity increases the proportion of slowly
migrating MeCP2 induced by the 60 min membrane depolarization. MeCP2 S421A neurons do not display this slowly migrating form of MeCP2 in response to
membrane depolarization.
(C) Quantification of western blot analysis for the forebrains of 4-week-oldMeCP2 S421Amice (n = 3) and their wild-type littermates (n = 3) using anti-total MeCP2
antiserum. Data are mean ± SEM. See also Figure S1.
(D) Immunocytochemistry of E16 + 22 DIV cortical neurons derived fromMeCP2 S421Amice andwild-type littermates using an antibody against total MeCP2 and
costaining with anti-histone H3 lysine 18 acetylation (H3K18Ac, active chromatin), antihistone H3 lysine 9 trimethylation (H3K9me3, heterochromatin) or anti-
histone H3 lysine 27 trimethylation (H3K27me3, repressed chromatin). Single 633 confocal planes of representative neuronal nuclei are shown.
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Development In Vitro and In Vivo
A major determinant of synapse formation and the integration of
neurons into a circuit is the pattern of dendritic arborization
receiving afferent input. Sensory-evoked neuronal activity has
been shown to stabilize connections between neurons through
the modulation of dendritic growth and patterning. Although
previous studies have implicated MeCP2 in dendritic growth
both in vitro and in vivo, it has not been possible to determine
if the absence of MeCP2 phosphorylation contributes to the
defects in dendritic growth that occur in RTT.
To investigate this possibility, we cultured cortical neurons
from the brains of wild-type and MeCP2 S421A mice and moni-
tored dendritic growth in these cultures. Sparse transfection of
GFP allowed visualization of the dendritic arbors of individual
cells, and cells with pyramidal morphology were imaged for
analysis of dendritic patterning at DIV 21-22. The Sholl method
of measuring dendritic complexity at a series of radii of in-
creasing distances from the cell soma revealed a significant
increase in the average number of dendritic branches in the
MeCP2 S421A mutant (Figures 2A and 2B). We conclude that
in cultured cortical neurons, MeCP2 S421 phosphorylation is
required for proper dendritic development. Calcium signaling
pathways initiated by neuronal activity influence both the net
growth of dendritic arbors as well as the refinement of dendritic
branching patterns (Wong and Ghosh, 2002). The increase in
dendritic complexity observed in the MeCP2 S421A cortical
neurons suggests that phosphorylation of MeCP2 in response
to activity might limit the initial phases of dendritic outgrowth,
or could help to refine the pattern of dendritic arborization in
response to synaptic signaling in subsequent phases of dendritic
development.
Pyramidal neurons are found primarily in forebrain structures,
and their distinct patterns of dendritic branching determine the
response of the cell to synaptic inputs (Spruston, 2008). To74 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.investigate whether MeCP2 S421 phosphorylation contributes
to dendritic patterning in the cortex in vivo, we crossed S421A
knockin mice to the GFP-M transgenic line that expresses
enhanced green fluorescent protein in a sparse subpopulation
of neurons throughout the brain (Feng et al., 2000), facilitating
morphological analysis of individual neurons. We examined
GFP-positive cortical layer V pyramidal cells in these experi-
ments because previous studies have shown that the disruption
ofMeCP2 function results in defects in dendritic growth of layer V
neurons, and also disrupts the synaptic connectivity of layer V
neurons within cortical circuits (Armstrong, 2002; Dani et al.,
2005; Dani and Nelson, 2009).
Sholl analysis of layer V pyramidal cells from MeCP2 S421A
mice and their wild-type littermates revealed a striking increase
in the complexity of MeCP2 S421A dendrites specifically within
the distal apical tuft located between 530–560 mm from the cell
soma, corresponding to the region of the apical tuft that extends
into layer I (Figures 2C–2E). Importantly, sensory experience is
required for the formation and maintenance of the dendritic
spines of these apical tuft dendrites (Holtmaat and Svoboda,
2009), and the regulation of dendritic complexity by MeCP2
S421 phosphorylation may represent a related mechanism of
experience-dependent neuronal development. In contrast to
apical tuft dendrites, the complexity of basal and proximal
apical dendrites did not differ significantly between the
MeCP2 S421A and wild-type cells. The fact that in cortical
circuits layer V pyramidal cells receive distinct types of synaptic
input on their basal, proximal apical, and distal apical dendrites,
together with our finding that MeCP2 S421 phosphorylation is
selectively required for the patterning of the distal apical
dendrites, suggests that MeCP2 phosphorylation at S421 may
be critical for specific aspects of activity-dependent circuit
development. Moreover, disruptions in this activity-dependent
process when MECP2 is mutated may contribute to features
of RTT.
Figure 2. Increased Dendritic Complexity upon Loss of MeCP2 S421 Phosphorylation
(A) Dissociated E16 + 21–22 DIV cortical neurons from MeCP2 S421A knockin mice or wild-type littermates transfected with GFP to visualize dendritic
morphology. Maximal intensity projections of a series of confocal planes for representative 253 images are shown.
(B) Sholl analysis measuring the number of dendritic branch points at 10 mm radial increments from the cell soma reveal an increase in dendritic branching in the
MeCP2 S421A cells (p < 0.05, two-way repeated-measures ANOVA) due to increased branch points 60–80 mm from the cell soma (p < 0.01, Bonferroni posttests).
Wild-type (n = 26) and MeCP2 S421A knockin (n = 33) neurons from two independent experiments.
(C) Representative images of single layer V pyramidal neurons expressing GFP under from the Thy1 promoter in 4-week-old forebrains of GFP-M transgenicmice.
Tracings are shown of maximal intensity projections of a series of 103 confocal planes taken from coronal cortical sections.
(D) Sholl analysis of dendritic branch points at 10 mm radial increments from the cell soma reveals an increase in dendritic branching of MeCP2 S421A layer V
pyramidal neuron apical dendrites 530 (p < 0.05), 540 (p < 0.01), 550 (p < 0.01), and 560 mm (p < 0.05) from the cell soma (two-way repeated-measures ANOVA
with Bonferroni posttests). Wild-type (n = 29) and MeCP2 S421A knockin (n = 16) neurons from three independent littermate pairs.
(E) The maximum number of dendritic intersectionsR400 mm from the cell soma observed by Sholl analysis of each GFP-M+ layer V pyramidal cell in MeCP2WT
and S421A knockin mice. The increase in maximum number of intersections in the MeCP2 S421A knockin cells compared to WT indicates that the MeCP2 S421
knockin apical tuft is more complex regardless of the exact distance of the apical tuft from the cell soma. p < 0.01 by Student’s t test. All data shown are
mean ± SEM.
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Excitation-Inhibition Balance
Given the importance of neuronal patterning for synaptic con-
nectivity, we reasoned that the increase in dendritic complexity
observed in the MeCP2 S421A cortex might reflect a role for
activity-dependent MeCP2 phosphorylation in cortical circuit
development. Although it has been proposed that MeCP2 regu-
lates experience-dependent aspects of synaptic maturation,
the specific importance of activity-dependent regulation of
MeCP2 in this context has not been demonstrated. To assess
the effect of loss of MeCP2 S421 phosphorylation on synaptic
development, we prepared acute slices containing primary
visual cortex (V1) from the brains of postnatal day 16–17
MeCP2 S421A mice and their wild-type littermates, and ob-
tained whole-cell patch-clamp recordings from layer II/III pyra-
midal neurons. Disruption of MeCP2 expression in the cortex
has indicated a general requirement for MeCP2 in cortical
neuron synaptic function (Guy et al., 2010). We analyzed pyra-
midal cells in cortical layer II/III of postnatal visual cortex
because of the well-defined role of neuronal activity in modu-lating the function of these cells (Maffei and Turrigiano, 2008;
Trachtenberg et al., 2000).
We analyzed pharmacologically isolated V1 layer II/III sponta-
neous miniature inhibitory postsynaptic currents (mIPSCs). We
saw no effect on the frequency of mIPSCs obtained from these
whole-cell patch-clamp recordings when wild-type and MeCP2
S421A mice were compared (Figures 3B and 3D). In contrast,
the amplitude of mIPSCs recorded from MeCP2 S421A neurons
in acute cortical slice were significantly increased relative to
neurons from wild-type samples (Figures 3C and 3E). The
increase in mIPSC amplitude observed in the MeCP2 S421A
brain suggests that the activity-dependent phosphorylation of
MeCP2 functions in the regulation of inhibitory synaptic strength,
and might reflect an increase in vesicle neurotransmitter content
or postsynaptic GABA receptor number. Analysis of pharmaco-
logically isolated spontaneous miniature excitatory postsynaptic
currents (mEPSCs) suggested a trend toward a decrease in the
frequency of mEPSC events in MeCP2 S421A knockin neurons
compared to wild-type neurons, although this change was not
statistically significant (Figure 4).Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 75
Figure 3. Loss of Activity-Dependent MeCP2 S421 Phosphorylation
Regulates Development of Inhibitory Synaptic Transmission In Vivo
(A) Representative traces of mIPSCs recorded from layer II/II V1 pyramidal
neurons in acute cortical slices from P16–17 MeCP2 S421A knockin mice or
their wild-type littermates.
(B and C) Cumulative probability distribution of mIPSC interevent intervals (B)
and amplitudes (C) recorded from MeCP2 S421A or wild-type littermates.
(D and E) Average interevent interval (D) and amplitude (E) of mIPSCs recorded
from wild-type or MeCP2 S421A neurons. Data are mean ± SEM. The differ-
ence in amplitude is statistically significant, p < 0.05 by Student’s t test. Data
shown represent 250 random events drawn from each of the wild-type (n = 19)
or MeCP2 S421A knockin (n = 21) cells analyzed, recorded from mice from six
independent litters.
Figure 4. Analysis of mEPSCs in the MeCP2 S421A Knockin Mouse
(A) Representative traces of mEPSCs recorded from layer II/II V1 pyramidal
neurons in P16–17 MeCP2 S421A knockin mice or their wild-type littermates.
(B and C) Cumulative probability distributions of mEPSC interevent intervals
(B) or amplitudes (C) recorded from MeCP2 S421A or wild-type littermates.
(D and E) Average interevent interval (D) and amplitude (E) of mEPSCs re-
corded from MeCP2 S421A or wild-type neurons. Data are mean ± SEM, p =
0.1 by Student’s t test. Data shown represent 250 random events drawn from
each of the wild-type (n = 23) or MeCP2 S421A knockin (n = 25) cells analyzed,
recorded from six pairs of littermates.
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MeCP2 S421 phosphorylation is required for the proper develop-
ment of synaptic connections within cortical circuits. Notably,
the overall shift in excitation-inhibition balance in the MeCP2
S421A knockin brain is similar in both direction and magnitude
to that described in the MeCP2 knockout animal (Dani et al.,
2005). The observed shift in the balance of synaptic inputs
onto pyramidal cells in favor of inhibition in the MeCP2 S421A
knockin cortex suggests that loss of the activity-dependent
phosphorylation of MeCP2 S421 may contribute to the synaptic
defects that have been observed in other mouse models of RTT.
Moreover the finding that S421 phosphorylation of MeCP2 is
important for the development of cortical inhibitory synapses is
consistent with the recent appreciation for the importance of76 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.activity-dependent programs of gene expression in regulating
the development of inhibition (Hong et al., 2008; Lin et al., 2008).
MeCP2 S421A Mutation Results in Abnormal Behavioral
Responses to Novelty
The alterations in cortical dendritic morphology and synaptic
function observed inMeCP2 S421Amice support the hypothesis
that activity-dependent regulation ofMeCP2 in neurons is critical
for normal brain development. Disruptions in brain development
such as those seen in the MeCP2 S421A mice can have a
profound impact on adaptive responses of the nervous system
throughout life, suggesting that the MeCP2 S421A mutation
might result in abnormal behavior in adult MeCP2 S421A mice.
We found that MeCP2 S421A mice are visually indistinguishable
from their wild-type littermates and show nomajor abnormalities
in motor activity levels or function (Figure S2). This made it
possible for us to assess whether MeCP2 S421A mice might
Figure 5. Defects in Behavioral Response to Novel Experience
in MeCP2 S421A Knockin Mice
(A) Sociability is not affected by loss ofMeCP2S421 phosphorylation. Behavior
of wild-type (n = 24) and MeCP2 S421A knockin (n = 21) mice in a three-
chamber apparatus with a single novel mouse placed in a small wire cage in
one of the side chambers. Data shown are time spent in each chamber over the
10-min trial period. Wild-type and S421A mice spent significantly more time in
the chamber with the novel mouse (WT, p < 0.001; S421A, p < 0.01). In this
assay wild-type and MeCP2 S421A mice were statistically indistinguishable.
(B) MeCP2 S421A mice do not lose interest in familiar mice. Behavior of wild-
type (n = 24) and MeCP2 S421A knockin (n = 21) mice in a three-chamber
apparatus with a familiar mouse placed in one of the side chambers and
a novel mouse placed in the opposite side chamber. Time spent in each
chamber over the 10-min trial period is shown. Wild-type mice spent signifi-
cantly more time with the novel mouse than with the familiar mouse or alone
(p < 0.01). The amount of time spent with each test mouse did not differ
significantly for MeCP2 S421A knockin mice.
(C) MeCP2 S421A mice do not distinguish between familiar and novel objects.
Behavior of wild-type (n = 9) and MeCP2 S421A (n = 9) mice when placed in an
Neuron
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Given the importance of MeCP2 in humans in the development
of neural circuits that underlie social functions and adaptability,
we analyzed the behavior of MeCP2 S421A mice using an assay
that was developed to assess sociability and the preference for
social novelty in mice (Moy et al., 2004).
MeCP2 S421A knockinmice or their wild-type littermateswere
placed in a three-chambered arena, and the behavior of themice
in this environment was monitored. A novel mouse that the test
subject had never before encountered was placed within a small
wire cage in one of the side-chambers of the arena. The test
subject chose whether or not to enter the chamber containing
the novel mouse, and the amount of time spent in each chamber
of the arena was recorded. Wild-type mice are social animals
and choose to spend more time in the chamber with another
mouse (Figure 5A). This social interaction behavior was unaf-
fected in MeCP2 S421A mice, demonstrating their ability to
recognize other mice and their appropriate interest in their phys-
ical and social environment. Subsequently, a secondmouse that
the test subject had never before encountered was placed within
a small wire cage in the side-chamber opposite to the first, now
familiar mouse. The wild-type test subjects spent the largest
proportion of their time in the chamber containing the second,
novel mouse and less time with the familiar choice (Figure 5B).
By contrast, the MeCP2 S421A mice spent as much time with
the familiar mouse as with the novel mouse.
Because the MeCP2 S421A mice show appropriate interest in
novel mice, it is unlikely that the increased time spent with
familiar mice is due to a general deficit in social recognition
upon loss of MeCP2 S421 phosphorylation. Likewise, the
MeCP2 S421A mice show no aversion to spending time alone
and appear normal in tests of anxious behavior (Figure S2).
Instead the increased interest in the familiar mouse suggests
that the MeCP2 S421A mutants cannot distinguish between
familiar and novel mice. This lack of discrimination between
novel and familiar stimuli exhibited by the MeCP2 S421A mice
was not limited to social behavior; when presented with both
novel and familiar inanimate objects, wild-type mice showed
a behavioral preference for a novel object, whereas the MeCP2
S421A mice spent equal amounts of time investigating both
familiar and novel objects (Figure 5C). This difference was
evident at 30 min after the initial exposure to the familiar object,
and persisted even after 24 hr had passed.
Taken together, these findings support the conclusion that
neuronal activity-dependent phosphorylation of MeCP2 at
S421 is necessary to allowan animal to process novel experience
and respond appropriately to previously encountered objects
or animals. This defect cannot be attributed to an absence of
all learning and memory in these mice, as the performance ofarena with a familiar inanimate object and a novel inanimate object placed at
opposite ends. In the short-term assay (i), the familiar object was first intro-
duced 30min prior to the trial. In the long-term assay (ii), the familiar object was
first introduced 24 hr prior to the trial. Wild-type mice spend significantly more
time interacting with the novel object than with the familiar object in both
assays (i, p < 0.01; ii, p < 0.05), whereas MeCP2 S421A knockin mice do not.
Total time spent exploring each object over a 10-min trial period is shown for
each assay. Data for all plots are mean ± SEM, p-values from one-way ANOVA
with Bonferroni multiple comparison correction.
Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 77
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MeCP2 S421 Phosphorylation in Neural Developmentthe MeCP2 S421A mice in spatial learning and memory tests is
indistinguishable from wild-type (Figure S3). Instead the specific
defect observed in the MeCP2 S421A mice suggests that the
activity-dependent phosphorylation of MeCP2 S421 contributes
to aspects of cognitive function underlying behavioral flexibility,
and that the disruption of this aspect of MeCP2 regulation
in RTT may be a factor in cognitive impairments observed in
affected individuals.
MeCP2 Binds to the Neuronal Genome in a Histone-Like
Fashion
The abnormalities we observe in the MeCP2 S421A knockin
animals demonstrate that this activity-dependent phosphoryla-
tion event is required for proper formation of the nervous system.
We considered how the phosphorylation of S421 might modu-
late the molecular function of MeCP2 during neuronal develop-
ment. Two distinct mechanisms have been proposed to explain
howMeCP2 functions when bound to DNA. Onemodel suggests
that MeCP2 acts as a transcriptional repressor, binding at the
promoters of specific target loci to prevent gene activation in
particular contexts. For example, semiquantitative chromatin
immunoprecipitation (ChIP) experiments suggested that in
neurons MeCP2 is bound specifically to the promoter of Bdnf
to repress the expression of this activity-dependent gene. In
response to neuronal activation the phosphorylation of MeCP2
at S421 was proposed to decrease MeCP2 binding to the Bdnf
promoter, relieving repression and thus permitting Bdnf tran-
scription (Chen et al., 2003; Martinowich et al., 2003). Subse-
quent studies have shown that MeCP2 binds near both active
and repressed genes (Chahrour et al., 2008; Wu et al., 2010; Ya-
sui et al., 2007), questioning whether binding of MeCP2 at
specific loci is sufficient to repress transcription. Most recently,
MeCP2 ChIP-Seq experiments demonstrated that MeCP2 binds
broadly throughout the genome (Skene et al., 2010), suggesting
that MeCP2 functions more like a histone protein than a
sequence-specific transcription factor. Thus it is possible that
MeCP2 regulates chromatin state globally rather than controlling
the level of gene transcription at specific loci.
To assess what effect S421 phosphorylation has on MeCP2
function, we determined the sites of MeCP2 binding across
the genome in untreated and membrane-depolarized neurons
using MeCP2 ChIP followed by high-throughput sequencing
(ChIP-Seq). We used antibodies raised against the C terminus
of MeCP2 that recognizes the protein regardless of its phosphor-
ylation state. We confirmed the specificity of the anti-MeCP2
antibodies for ChIP from mouse brain and cultured cortical
neurons using quantitative PCR across the Myc locus, a region
shown to be bound by MeCP2 (Skene et al., 2010) (Figure S4A).
We then performed ChIP-Seq from cultured neurons that were
either left unstimulated or membrane depolarized with high
extracellular KCl for 2 hr. Mapping of theMeCP2ChIP-Seq reads
to the genome revealed a broad distribution of MeCP2 in both
unstimulated and membrane depolarized neurons (Figure 6A).
MeCP2 ChIP-qPCR confirmed that the distribution of reads
obtained by ChIP-Seq represents broad distribution of MeCP2
across the genome rather than failure of the ChIP to enrich for
MeCP2-bound DNA: we observed at least 20-fold enrichment
above peptide-blocked control ChIP at all sites tested, including78 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.regions surrounding activity-regulated genes, constitutively
active loci, and repetitive genomic elements (Figure 7A).
The broad distribution of MeCP2 that we detect is similar to
that previously reported (Skene et al., 2010). Notably, the
previous MeCP2 ChIP analysis was carried out using brain
extracts and an antibody that recognizes an N-terminal region
of MeCP2. In the present study we have used cultured neurons
and an anti-C-terminal-MeCP2 antibody. The fact that similar
results are obtained using two different anti-MeCP2 antibodies
provides support for the conclusion that MeCP2 binds broadly
across the neuronal genome.
The relatively uniform distribution of MeCP2 ChIP-Seq reads
that we observe is inconsistent with the idea that MeCP2 binds
at discrete sites within the regulatory regions of target genes.
This point is illustrated by comparison of the pattern of MeCP2
binding to that of canonical transcription factors. For example,
CREB is a sequence-specific DNA-binding factor critical for
activity-dependent gene regulation in neurons that has been
suggested to associate with MeCP2 (Chahrour et al., 2008).
Previous CREB ChIP-Seq analysis performed in neuronal
cultures identical to those used for our MeCP2 ChIP-Seq (Kim
et al., 2010) demonstrates that CREB binds to the genome at
discrete sites (Figure 6A). Peaks of CREB binding are defined
by a peak detection algorithm that identifies regions with high
enrichment of reads relative to the average genomic distribution
(Figure 6B). In contrast, genome-wide peak detection analysis of
total MeCP2 ChIP reads identified modest fluctuations in protein
binding, and the read enrichment for these regions was substan-
tially lower than that of the CREB peaks (Figure 6B and data not
shown).
Instead the read distribution of MeCP2 across the genome is
quite similar to histone H3 ChIP-Seq data obtained from mouse
embryonic stem cells (Mikkelsen et al., 2008), suggesting that
MeCP2 may function more like a histone than a classical tran-
scriptional repressor. To compare the profile of H3 to MeCP2,
we performed genome-wide peak detection analysis for this
histone H3 ChIP-Seq and, as for MeCP2, were able to identify
only modest fluctuations in protein binding with relatively low
read enrichment within these identified regions (Figure 6B). The
similarities between the binding profiles of MeCP2 and histone
H3 support the hypothesis that MeCP2 functions as a core
component of neuronal chromatin.
MeCP2Binding Profiles AreMaintained during Neuronal
Activation
It has been suggested that neuronal activation and subsequent
phosphorylation of MeCP2 reduces the affinity of MeCP2 for
DNA, providing a mechanism through which extracellular stimuli
could regulate neuronal chromatin. Local alterations in the
binding of MeCP2 at particular genes in response to neuronal
stimuli could allow this histone-like factor to affect the transcrip-
tion of individual target genes. To test this hypothesis, we exam-
ined MeCP2 binding profiles in neurons before and after mem-
brane depolarization. Genome-wide comparisons by MeCP2
ChIP-Seq revealed no evidence of robust changes in MeCP2
binding between the two conditions (Figure 6C). Moreover, com-
putational searches for regions of significantly increased or
reduced binding failed to detect reproducible changes in the
Figure 6. ChIP-Seq Analysis Reveals a Histone-Like Binding Profile for Total MeCP2 and Global Phosphorylation of MeCP at S421 upon
Neuronal Stimulation
(A) ChIP-Seq profiles for total and pS421 MeCP2 as well as CREB, CBP, and H3K4me3 (Kim et al., 2010) across a representative genomic region. ChIP samples
were isolated from E16 + 7 DIV cortical cultures, unstimulated () or stimulated for 2 hr with 55 mM KCl (+). The location of RefSeq genes, including the activity-
regulated immediate-early gene Junb, are indicated.
(B) Box plots (first quartile, median, and third quartile) displaying the ratio of the number of reads found at called peaks versus nonpeak control regions are shown
for each ChIP-seq data set (2 hr KCl stimulated). Enrichment for pan-histone H3 ChIP-Seq peaks from embryonic stem cells is shown for comparison (H3ES)
(Mikkelsen et al., 2008).
(C) Scatter plots depict normalized ChIP-Seq reads from E16 + 7 DIV cortical cultures for 1000 bp windows tiled across the genome before and after stimulation
(2 hr KCl). Data points on the diagonal indicate no substantial change in ChIP signal upon stimulation. Points located off the diagonal, as seen for CBP, indicates
dynamic change in response to neuronal activity.
(D) Scatter plot depicts normalized ChIP-Seq reads of pS421 MeCP2 versus total MeCP2 from stimulated dissociated cortical cultures (E16 + 7 DIV, 2 hr KCl)
for 1000 bp windows tiled across the genome. Distribution along the diagonal indicates that the profile of pS421 reads tracks with total MeCP2 reads across
the genome.
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trast, analysis of ChIP-Seq data for the transcriptional coactiva-
tor CBP in the identical neuronal culture and stimulation para-
digm (Kim et al., 2010) reveals a dramatic increase in the
binding of CBP across the genome in response to membrane
depolarization, demonstrating our ability to detect dynamic
changes in factor binding (Figure 6C).We note that the widespread distribution of MeCP2 ChIP-Seq
reads across the genome limits our power to detect a loss of
MeCP2 binding occurring over small regions due to low read
coverage. To address this, we analyzed MeCP2 binding at mul-
tiple loci before and after membrane depolarization in neurons
using more targeted and sensitive ChIP-qPCR. We failed to
detect any significant changes in MeCP2 binding across theNeuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 79
Figure 7. ChIP-qPCR and Immunohistochemistry Confirm Broad
Binding of Total MeCP2 and Global MeCP2 S421 Phosphorylation
In Vitro and In Vivo
(A) ChIP-qPCR analysis of total MeCP2 (top) and pS421 MeCP2 (bottom) in
cultured cortical neurons (E16 + 7 DIV) that were either membrane depolarized
for 2 hr (55 mM KCl) or left unstimulated.
(B) Total MeCP2 (left) and pS421MeCP2 (right) ChIP-qPCR from the forebrains
of 7-week-old MeCP2 S421A mice or their wild-type littermates. The location
of PCR amplicons across the Bdnf locus are shown in diagram as a–j.
Nucleotide position is given relative to start of the activity-dependent Bdnf
promoter IV. All ChIP data is presented as fold enrichment above a negative
control ChIP performed in parallel on each sample using the same antiserum
that had been preincubated with the peptide antigen to which it was raised.
Data are mean ± SEM from three independent experiments.
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80 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.promoters of multiple activity-dependent genes in neuronal
cultures (Figure 7A), or in the brains of wild-type and MeCP2
S421Amice (Figures 7B and Figure S4). In addition, we detected
no activity-induced changes in MeCP2 ChIP signal at a number
of constitutively expressed genes and repetitive loci (Figure 7A
and Figure S4). These data indicate that in this neuronal stimula-
tion paradigm, where 10%–30% of the MeCP2 molecules
become newly phosphorylated at S421 (Figure 1B and data
not shown), there is no evidence of dynamic changes in
MeCP2 binding. Although it remains possible that phosphoryla-
tion of additional sites or distinct stimulation conditions lead to
dissociation of MeCP2 from the genome as reported previously
at the Bdnf locus (Chen et al., 2003; Martinowich et al., 2003), we
conclude that phosphorylation of MeCP2 S421 alone is not suffi-
cient to releaseMeCP2 fromDNA. It is possible that the previous
reports demonstrating decreased MeCP2 binding to DNA upon
membrane depolarization reflect that fact that the ChIP assays
used at the time were semiquantitative and therefore more
subject to error.
Activity-Dependent Transcriptional Programs Are Not
Affected in S421A Mutants
Although our MeCP2 ChIP analysis suggests that neuronal
activity does not induce changes in the binding of MeCP2 to
DNA, it remained possible that the phosphorylation of MeCP2
bound to the promoters of activity-regulated genes might regu-
late activity-dependent gene transcription. To examine this
possibility, we compared the level of activity-dependent Bdnf
expression in dissociated primary cortical cultures from the
brains of MeCP2 S421A mice and their wild-type littermates by
RT-qPCR. Given previous studies showing that when MeCP2
is overexpressed in neurons the phosphorylation of MeCP2 at
S421 affects Bdnf transcription (Zhou et al., 2006), we were
surprised to find that the extent and time course of Bdnf induc-
tion upon membrane depolarization was not significantly dif-
ferent between wild-type and MeCP2 S421A neurons (Figure S5
and data not shown). Likewise, the kinetics of induction of other
activity-regulated genes, such as c-fos, were similar in wild-type
and MeCP2 S421A neurons.
Given these results, we broadened our approach and used
Affymetrix GeneChip Mouse Expression Set 430 2.0 microarrays
to assess whether loss of MeCP2 S421 phosphorylation affected
global profiles of activity-dependent gene expression. Cortical
neurons isolated from the brains of embryonic MeCP2 S421A
mice and their wild-type littermates were grown for 7 DIV then
depolarized with KCl for 1 or 6 hr. Although we detected more
than 300 genes whose expression levels changed at least
3-fold in response to extracellular KCl, we found no significant
differences in the number, extent, or time course of induction of
activity-dependent mRNAs between the wild-type and MeCP2
S421A cells (Figure S5).We also usedMouseGene 1.0 STmicro-
arrays to assessmRNA levels in the visual cortex of postnatal day
16–17 wild-type and MeCP2 S421A knockin brains, a time point(C) Immunocytochemistry of nuclei fromwild-type E16 + 10DIVmouse cortical
neurons following 30 min membrane depolarization with 55 mM KCl. Anti-
bodies used are specific for total MeCP2 or pS421 MeCP2 (see also Fig-
ure S4). Representative 633 images from single confocal planes are shown.
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probes within specific gene regions or groups of probes across
individual genes revealed no detectable mRNA dysregulation in
the developing MeCP2 S421A mouse brain (data not shown). It
remains possible that S421 phosphorylation has more subtle
effects on the magnitude or timing of activity-dependent gene
transcription. Alternatively, MeCP2 S421 phosphorylation may
control aspects of transcription (e.g., initiation, elongation, termi-
nation, or the rate of transcription) or chromatin remodeling (e.g.,
histone modification and compaction or DNA methylation) that
are not detected by measuring steady-state mRNA levels. It is
also possible that other mechanisms of gene regulation largely
compensate in the absence of MeCP2 S421 phosphorylation.
Phosphorylation of MeCP2 S421 Occurs Globally
in Response to Neuronal Stimulation
To further investigate how S421 phosphorylation might affect
MeCP2 function, we employed ChIP-Seq to examine where
across the genome MeCP2 becomes newly phosphorylated at
S421 in response to neuronal activity. We hypothesized that if
pS421 MeCP2 controls a specific step in the process of
activity-dependent gene transcription, then this phosphorylation
event would be expected to occur at select regions of the
genome (e.g., the promoters, enhancers, or exons of activity-
dependent genes).
We first sought to establish the utility of our anti-pS421MeCP2
specific antiserum for ChIP analysis (Figure 1A and Figure S4B).
We immunoprecipitated pS421 MeCP2 from unstimulated or
KCl-depolarized neurons and from the brains of wild-type or
MeCP2 S421A knockin mice. qPCR analysis of several loci
demonstrated that the anti-pS421 MeCP2 antibody specifically
recognizes the phosphorylated form of MeCP2 in ChIP assays:
pS421 MeCP2 was found to be bound at all sites tested in
membrane-depolarized neurons but not in unstimulated neurons
where the level ofMeCP2 S421 phosphorylation is quite low (Fig-
ure 7A), and was enriched in wild-type brain compared to
MeCP2 S421A brain (Figure 7B). Moreover, the pS421 MeCP2
ChIP signal was competed away if the anti-pS421 MeCP2 anti-
serum was preincubated with the phospho-peptide antigen
used to generate the antibody (Figure S4C).
To determine where along the genomeMeCP2 S421 becomes
phosphorylated in response to neuronal activation, we per-
formed high-throughput sequencing of pS421 MeCP2 ChIP
DNA isolated from cultured cortical neurons treated with
55mM KCl for 2 hr. Mapping of the sequenced pS421-MeCP2
ChIP reads to the genome revealed a strikingly uniform distribu-
tion of pS421 MeCP2 with little evidence of discrete peaks (Fig-
ure 6A), indicating that upon membrane depolarization MeCP2
bound broadly across the genome is phosphorylated at S421.
We considered the possibility that the genomic distribution of
pS421 MeCP2 might be similar to that previously reported for
specific histone modifications. Although histone modifications
can be broadly distributed across the genome, it is possible to
identify genomic elements that bear a particular mark whereas
other regions of the genome are devoid of the histone modifica-
tion. For example, although histone H3 lysine 4 trimethylation
(H3K4me3) can span 500 bp to 2 kb surrounding promoters,there are genomic regions where this mark is absent (Zhou
et al., 2011). Othermarks, such as H3S10 phosphorylation occur
throughout the genome (Nowak and Corces, 2004). Importantly,
the presence of these histone marks can be informative. For
example, the H3K4me3 mark occurs at expressed genes,
whereas H3S10 phosphorylation is found across the genome
as a hallmark of mitosis.
To scan for regions of the genome that are enriched for pS421
MeCP2we searched for peaks across the genome, changing the
parameters of the peak detection algorithm to detect peaks of
different length scales. The loci identified by this approach re-
vealed only very modest increases in sequencing reads relative
to nonpeak regions of the genome, supporting the conclusion
that in membrane depolarized neurons pS421 MeCP2 is wide-
spread across the genome (Figure 6B).
Finally, we considered the possibility that within the ubiquitous
distribution of pS421MeCP2 across the genome there might still
be regions of relative enrichment. Because the pS421 MeCP2
ChIP-Seq analysis revealed some modest peaks of MeCP2
binding, we used ChIP-qPCR to ask if these putative pS421
MeCP2 peaks could be validated. However, an analysis of nine
candidate peaks revealed that none displayed greater than a
2-fold increase in signal above flanking, nonpeak control
regions. Importantly, all peak and nonpeak regions tested dis-
played robust pS421 MeCP2 ChIP signal from depolarized
neurons relative to pS421 MeCP2 ChIP signal from unstimulated
neurons (Figure S4F), supporting the conclusion that upon
membrane depolarization MeCP2 located throughout the
genome becomes newly phosphorylated at S421. Indeed, in
membrane depolarized neurons, genome-wide comparison of
the pS421 and total MeCP2 ChIP-Seq reads shows that pS421
MeCP2 tracks well with total MeCP2 (Figure 6D). The wide-
spread phosphorylation of MeCP2 is also evident in the brain
where pS421 MeCP2 ChIP-qPCR across multiple loci shows
a strong correlation to total MeCP2 ChIP-qPCR and significant
enrichment above parallel ChIP experiments performed with
MeCP2 S421A brain (Figure 7B and Figure S4). Finally, immuno-
staining with the anti-pS421 MeCP2 antibody revealed that in
wild-type neurons pS421 MeCP2 colocalizes with total MeCP2
throughout the nucleus (Figure 7C). Taken together, these obser-
vations indicate that in response to membrane depolarization in
neurons, phosphorylation of S421 is evenly distributed across
MeCP2 molecules bound throughout the genome. Phosphoryla-
tion therefore occurs at active and repressed promoters; in-
tronic, exonic, and intergenic sequences; and repetitive regions
and transposon sequences. Thus, rather than serving as a locus-
specific mechanism for regulating the expression of particular
mRNA transcripts, MeCP2 S421 phosphorylation appears to
facilitate a global chromatin response to neuronal activation
that likely underlies some aspect of chromatin remodeling that
occurs in response to neuronal activity. The absence of this
response in MeCP2 S421A mice may account for the dendritic,
synaptic, and behavioral defects that we observe.
DISCUSSION
Intense investigation has focused on determining howmutations
of MECP2 lead to RTT and related neurological disorders. TheNeuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 81
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synaptic defects observed in Mecp2 mutant mice have led to
the hypothesis that RTT is a disorder of experience-dependent
synapse maturation. However, the devastating consequences
of loss or overexpression of MeCP2 on cell and organismal
health have made it difficult to assess whether defects in expe-
rience-dependent synaptic and cognitive development arise
directly from, or are indirect consequences of, loss of MeCP2
function. Indeed, careful observation of individuals with RTT
has suggested that different mutations in MECP2 can lead to
distinct cognitive and clinical sequelae (Neul et al., 2008), sug-
gesting that MeCP2 has a number of discrete roles in the devel-
opment of the nervous system.
The discovery that experience induces the phosphorylation of
MeCP2 at S421 in the brain revealed a mechanism by which
neuronal activity might modulate MeCP2 function, and has
provided a molecular handle to dissect the activity-dependent
and -independent functions of MeCP2. In the present study we
eliminated the neuronal activity-dependent phosphorylation of
MeCP2 at S421 in vivo without otherwise affecting MeCP2
expression. By studying these MeCP2 S421A mice, we find
that MeCP2 S421 phosphorylation is required for the normal
development of neuronal dendrites and inhibitory synapses in
the cortex, demonstrating the importance of the activity-depen-
dent regulation of MeCP2 for the establishment of appropriate
connectivity in the nervous system. In addition, we find that
loss of MeCP2 S421 phosphorylation results in defects in behav-
ioral responses to novel versus familiar mice or objects, indi-
cating that activity-dependent MeCP2 phosphorylation regu-
lates aspects of cognitive function. Based on these findings,
we propose that the disruption of MeCP2 phosphorylation at
S421 contributes to the cognitive impairments observed in RTT
and other MECP2-dependent disorders.
Compared to the effects of deleting Mecp2, mutating MeCP2
S421 to an alanine has a relatively mild effect on nervous system
development. For example, the gross motor abnormalities, body
weight dysregulation, seizures, and certain learning andmemory
defects observed in the MeCP2 knockout appear not to rely on
the activity-dependent phosphorylation of MeCP2 at S421.
This could suggest that aspects of MeCP2-regulated neuronal
function rely on neuronal activity-independent development
processes. Alternatively, it is possible that other stimulus-depen-
dent MeCP2 modifications (D.H.E. and M.E.G., unpublished
data) may function either singly or in combination to regulate
MeCP2-dependent neuronal responses.
It has been proposed, based on mass spectrometry analysis
(Tao et al., 2009), that phosphorylation of MeCP2 also occurs
at serine 424 (S424). A recent study reports that the mutation
of bothMeCP2S421 andS424 to alanines inmice results in alter-
ations in hippocampal learning and synapse biology as well as
changes in MeCP2 binding and dysregulation of a small number
of candidate genes examined (Li et al., 2011). The phenotypes
reported in these mice are similar to the phenotypes observed
whenMeCP2 is overexpressed inmice (Chao et al., 2007; Collins
et al., 2004) raising the possibility that the mutation of S424 to
alanine leads to enhanced MeCP2 expression or activity.
In an effort to determine if neuronal activity induces the phos-
phorylation of MeCP2 S424 we have generated antiphospho-82 Neuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc.S424 MeCP2-specific antibodies, but we have been unable to
detect increased phosphorylation of MeCP2 S424 in response
to neural activity in vitro (KCl depolarized versus unstimulated
cortical cultures,) or in vivo (kainate seized versus unseized
brain) (D.H.E. andM.E.G., unpublished data). Although it remains
possible that MeCP2 S424 is phosphorylated constitutively or
in response to other stimuli, we have restricted our analysis to
the verified activity-dependent phosphorylation of MeCP2 at
S421, allowing us to unambiguously relate the phenotypes we
observe in MeCP2 S421A mice to activity-dependent MeCP2
phosphorylation.
Our observations using MeCP2 S421A mice reinforce the
importance of in vivo models for studying the role of neuronal
activity in nervous system development and function. Previous
in vitro studies suggested a model in which, in the absence of
neuronal activity, MeCP2 is bound to the promoters of activity-
regulated genes such as Bdnf to repress their transcription
(Chen et al., 2003; Martinowich et al., 2003; Zhou et al., 2006).
Membrane depolarization-induced S421 phosphorylation was
proposed to lead to reduced binding of MeCP2 at these
activity-dependent promoters, relieving repression and allowing
for gene activation. If this model were correct, we would predict
that neurons from MeCP2 S421A mice might demonstrate a
defect in the induction of Bdnf or other activity-regulated genes.
Instead, we found that the activity-dependent expression of
Bdnf and other neuronal activity-dependent genes was not de-
tectably dysregulated by loss of MeCP2 phosphorylation at
S421, suggesting that this model of activity-dependent MeCP2
function must be revised.
To reassess the molecular function of MeCP2 and its regula-
tion by neuronal activity, we turned to ChIP-Seq to examine
the binding profile of MeCP2 genome-wide. Recent work from
brain had suggested that MeCP2 binds broadly across the
genome (Skene et al., 2010). By demonstrating that MeCP2 is
highly enriched throughout the genome in both the brain and
dissociated cortical cultures that contain very few glial cells,
we exclude the possibility that the broad binding of MeCP2
observed in the brain arises as a result of heterogeneous contri-
butions from neuronal and glial populations. Consistent with this
recent study (Skene et al., 2010), the pattern of bindingwe detect
in brain and neurons suggests that MeCP2 binds preferentially to
methylated DNA (i.e., reduced binding at TSS sites, increased
binding at repeat DNA). However, MeCP2 binding is not limited
to methylated loci, as we note a high level of signal in MeCP2
ChIP assays from brain and cultured neurons at sites where
DNA methylation is presumably very low (e.g., the TSS for the
highly-expressed Myc gene), or devoid of CpG residues over
long stretches. Interestingly, the ChIP profile of MeCP2 in
E16 + 7 DIV cortical cultures is more flat than that found in the
brains of 7-week-old mice (e.g., Figure S4A), suggesting that
changes in DNA methylation or MeCP2 expression levels during
nervous system development may lead to an increase in the
dynamic range of the MeCP2 binding profile.
Taken together, our ChIP data allow us to conclude that
MeCP2 is bound throughout the neuronal genome in a pattern
similar to that of a histone protein. Several studies have demon-
strated that MeCP2 binds to the linker DNA between nucleo-
somes in vitro similarly to linker histone H1 (Ghosh et al., 2010;
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lated in the MeCP2 knockout brain (Skene et al., 2010). Our
data is consistent with a model in which MeCP2 takes the place
of H1 molecules throughout the neuronal genome, functioning
on a global scale to modulate chromatin structure.
By examining genome-wide profiles of MeCP2 before and
after neuronal stimulation, we have assessed the potential for
dynamic regulation of MeCP2 binding by activity-dependent
phosphorylation. Under the conditions used for these experi-
ments, S421 phosphorylation is induced on a substantial fraction
of MeCP2molecules, yet we do not detect changes in the profile
of MeCP2 binding across the genome. Because of the broad
distribution of MeCP2, low read coverage limits our power to
detect discrete regions where binding may be lost. However,
using more sensitive ChIP-qPCR at multiple candidate activity-
dependent loci we are unable to detect stimulus-dependent
changes in binding. Consistent with this finding, seizure-induced
increases in neuronal activity do not detectably alter MeCP2
binding at the activity-regulated promoter of Bdnf (H.W.G.,
M.E.G., and B. Kinde, unpublished data). Although it remains
possible that a small number of discrete sites experience
changes in binding or that there is a subtle change in global
binding within the variability of our experiments, our data
suggest that a stimulus capable of robustly inducing MeCP2
S421 phosphorylation is not sufficient to cause MeCP2 dissoci-
ation from the genome. Furthermore, because our stimuli induce
the expression ofBdnf and other activity-regulated genes, disso-
ciation of MeCP2 from the DNA is not strictly required for tran-
scriptional induction of these genes. Instead it appears that
neuronal activity induces the phosphorylation of MeCP2 mole-
cules that remain bound to the genome, serving to modulate
MeCP2 function in situ.
Given the histone-like binding of MeCP2 to the neuronal
genome, we considered that the phosphorylation of MeCP2
S421 could function in a manner analogous to a histone modifi-
cation. Although studies of pan-histone genomic binding profiles
have provided important information about chromatin structure,
ChIP analysis of specific histone modifications has led to a rich
understanding of the localization and dynamics of these modifi-
cations, providing insight into their function in the modulation of
gene expression (Zhou et al., 2011). As a first step toward under-
standing where posttranslational modifications of MeCP2 occur
on the genome, we performed ChIP analysis using a specific
pS421 MeCP2 antiserum. We demonstrate that the neuronal
activity-induced phosphorylation of S421 is evenly distributed
across MeCP2 molecules bound to the genome. We estimate
the percentage of MeCP2 phosphorylated at S421 in response
to neuronal stimulation (2 hr KCl depolarization) to be 10%–
30%. If one MeCP2 molecule is bound every two nucleosomes
as demonstrated by (Skene et al., 2010), and phosphorylation
is evenly distributed across MeCP2molecules, then an indepen-
dent phosphorylation event is occurring approximately every
900–3000 bp. Thus, pS421 MeCP2 is likely to be extremely
common across the genome, and has the potential to affect
chromatin at a genome-wide scale. These findings suggest
that instead of regulating specific target genes, MeCP2 S421
phosphorylation likely plays a more global role in modulating
the response of neuronal chromatin to activity.Although many histone modifications have been found in
discrete loci, genome-wide phosphorylation of histone H3
(e.g., H3S10) and histone H1 are thought to facilitate mitotic
chromosomal rearrangements in non-neuronal cells (Happel
and Doenecke, 2009; Nowak and Corces, 2004). This precedent
suggests that the global phosphorylation of MeCP2 may alter
chromatin compaction states throughout the nucleus or facilitate
nuclear reorganization events that have been reported to occur
in response to neuronal activity (Wittmann et al., 2009). As a
result, the phosphorylation of MeCP2 S421 may play a role in
fine-tuning aspects of gene expression that are not readily de-
tectedwith standardmeasures of gene expression. Alternatively,
the global phosphorylation of MeCP2 S421 could collaborate
with locus-specific modifications of MeCP2: S421 phosphoryla-
tion would facilitate transcriptional processes specifically gated
by other stimulus-dependent modifications of MeCP2. Either of
thesemodels could explain why we observe phenotypes consis-
tent with defects in experience-dependent neuronal develop-
ment upon loss of MeCP2 S421 phosphorylation, but are unable
to detect significant changes in the expression of individual
genes.
Together with recent analysis (Skene et al., 2010), our data
support a conceptual shift in the understanding of the function
of MeCP2 in neurons. Instead of acting solely as a repressor to
regulate gene expression through targeted, dynamic binding to
chromatin, it may be more appropriate to consider MeCP2
as a constitutive component of neuronal chromatin. The idea
that MeCP2 has many functions is consistent with the discovery
of multiple, independently occurring phosphorylation events on
MeCP2 (Huttlin et al., 2010; Tao et al., 2009; Zhou et al., 2006)
(D.H.E. and M.E.G., unpublished data) and the finding that total
loss or overexpression of MeCP2 leads to subtle changes in
the expression of thousands of genes rather than derepression
of a discrete subset of target genes. Just as different histone
modifications can correlate with independent and often op-
posing effects on gene expression, the different modifications
of MeCP2 may have distinct influences on chromatin at sites
where they occur. The experiments presented here demonstrate
that it is possible to perform modification-specific ChIP analysis
of MeCP2 to gain insight into its global role. Future studies
employing this approach may indicate where additional phos-
phorylation events occur on the genome and provide insight
into how they modulate MeCP2 function.
By revealing the functional role of MeCP2 S421 phosphoryla-
tion, the MeCP2 S421A mouse demonstrates the utility of
an in vivo approach for testing hypotheses regarding activity-
dependent regulation of MeCP2. Moreover, the phenotypes
observed in the MeCP2 S421A mice provide in vivo evidence
that the stimulus-dependent modification of a chromatin
regulator is required for nervous system development and func-
tion. Additional knockin mutations to disrupt other activity-
dependent modifications of MeCP2 may provide useful models
for further study of stimulus-dependent regulation of MeCP2
in vivo, and should yield insight into the role of the environment
in regulating neuronal chromatin function. Finally, given the
critical importance of MeCP2 for nervous system development,
future experiments to understand activity-dependent MeCP2
regulation will not only serve to deepen our understanding ofNeuron 72, 72–85, October 6, 2011 ª2011 Elsevier Inc. 83
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vide therapeutic insight into RTT and other neuropsychiatric
disorders.
EXPERIMENTAL PROCEDURES
Generation of MeCP2 S421A Knockin Mice
Targeting of the MeCP2 locus was carried out by homologous recombination
(Figure S1) in ES cells. A detailed description of animal breeding and genotyp-
ing is provided in the Supplemental Experimental Procedures.
Neuronal Cell Culture, Protein Expression, Immunocytochemistry,
and Immunohistochemistry Analysis
Cortical or hippocampal neurons were prepared from E16 mouse embryos as
described by Kim et al. (2010). Western blotting, immunocytochemistry, and
immunohistochemistry were carried out using standard methods. Sholl
analysis of dendritic morphology was performed using Neurolucida (MBF
Bioscience) software on images acquired by confocal microscopy. For details
see Supplemental Experimental Procedures.
Chromatin Immunoprecipitation Analysis
ChIP experiments were performed as previously described (Kim et al., 2010)
with some modifications. Immunoprecipitation was performed using custom
rabbit polyclonal antisera recognizing either total MeCP2 or phosphoserine
421 MeCP2 (Zhou et al., 2006). ChIP-Seq was performed using the SOLiD
instrument (Life Technologies) as previously described (Kim et al., 2010),
with slight modifications. For a description of computational analysis and
experimental details see Supplemental Experimental Procedures.
Gene Expression Analysis
For gene expression in cultured neurons or brain tissue, total RNAwas isolated
and cDNA generated using standard methods. qPCR analysis was carried out
using the StepOnePlus system (Life Technologies, Beverly, MA). Microarray
analysis of cultured wild-type and S421A neuron RNA samples was carried
out using Affymetrix GeneChip Mouse Expression Set 430 2.0 microarrays
arrays. Microarray analysis from visual cortex employed total RNA isolated
from P17 mice and analyzed on Affymetrix Mouse Gene 1.0 ST microarrays.
See Supplemental Experimental Procedures for details.
Electrophysiology
Whole-cell voltage clamp recordings were measured from layer II/III pyramidal
neurons in coronal sections (250 mm) containing the primary visual cortex of
P16–P17 mice. For both amplitude and interevent interval, 250 events were
randomly selected from each cell. See Supplemental Experimental Proce-
dures for details.
Behavioral Analysis
The assay of sociability and preference for social novelty were based on awell-
characterized assay from the Crawley lab (Moy et al., 2004). For details of all
behavioral analyses see Supplemental Experimental Procedures.
ACCESSION NUMBERS
All microarray and high-throughput sequencing data are available in the GEO
archive under SuperSeries accession number GSE31851.
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